Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Diabetes Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
CGT Research Outlook and Technology Growth Opportunities
... therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, and expansion to new disease areas. Over ... Read More
-
Global Cord Blood Banking Services Market Size Study, by Storage Services (Public Cord Blood Banks, Private Cord Blood Banks), by Component (Cord Blood, Cord Tissue), by Application (Cancer Disease, Diabetes, Blood Disease, Immune Disorders, Metabolic Disorders, Others), and Regional Forecasts 2022-2032
... Disorders, Others), and Regional Forecasts 2022-2032 Global Cord Blood Banking Services Market is valued at approximately USD 1.89 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 13.3% ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Diabetic Nephropathy Treatment
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Angiotensin Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.8 ... Read More
-
Injection Pens
... at a CAGR of 5.9% over the analysis period 2023-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end ... Read More
-
Global Alpha Glucosidase Inhibitors Market 2024-2028
... forecast period. The report on the alpha glucosidase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Short-Acting Insulin - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Store & Retail Pharmacies, and Online Providers), and Geography (North America, Europe, Asia-Pacific, and rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of ... Read More
-
Artificial Pancreas Device Systems
... reach US$1.5 Billion by 2030, growing at a CAGR of 18.8% over the analysis period 2023-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR ... Read More
-
Rare Endocrine Disease Treatment
... reach US$14.4 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Acromegaly Treatment, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More
-
Chronic Disease Management Market, By Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, and Others (Arthritis, etc.)), By Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth Services, and Others (Diagnostic Services, etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) ... Read More
-
Diabetic Food
... at a CAGR of 4.7% over the analysis period 2023-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$6.2 Billion by the end of ... Read More
-
Diabetes Drugs
... at a CAGR of 9.3% over the analysis period 2023-2030. Insulin, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$123.1 Billion by the end of the ... Read More
-
2024 Global Forecast for Diabetic Foot Ulcer Treatment (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Trypsin-EDTA Solution for Cell Dissociation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (0.25% Solution, 0.05% Solution), By Application (Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other) By Region and Competition, 2019-2029F
... 2019-2029F Global Trypsin-EDTA Solution for Cell Dissociation Market was valued at USD 1.05 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.24% through 2029. The ... Read More
-
Point of Care Diagnostics Market By Product: Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others; By End User: Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-testing, Regional Outlook - Global Forecast up to 2030
... and Homecare/Self-testing, Regional Outlook - Global Forecast up to 2030 We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content ... Read More
-
Global Neuropathic Pain Market Size Study, by Drug Class (Antidepressants, Anticonvulsant, Opioids, Capsaicin, Others), by Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Others), by Distribution Channel (Hospital Pharmacies, Drugs Stores and Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032
... Pharmacies) and Regional Forecasts 2022-2032 The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the ... Read More
-
Global Acute Rehabilitation Market Size Study, by Phase Type (Phase I- Acute Phase, Phase II- Subacute Phase, Phase III- Intensive Outpatient Therapy, Phase IV- Independent Ongoing Conditioning), by Devices Product (Blood Pressure Monitor, Heart Rate Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure or Transplant, High Blood Pressure, Pulmonary Hypertension), by End User (Home Care, Hospitals & Clinics, Rehabilitation Centers, Specialty Centers), and Regional Forecasts 2022-2032
... Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure ... Read More
-
Connected Diabetes Care: Innovations and Growth Opportunities
... finger-stick blood sugar testing is increasing, especially in type 1 diabetics (T1D). HbA1c and time-in-range are currently the preferred biomarkers for diabetes monitoring applications. Emerging diet and fitness tracking apps help support general well-being and ... Read More
-
Global Type 2 Diabetes Market 2024-2028
... type 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Insulin Syringes Market 2024-2028
... report on the insulin syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose, Tablets), ROA (Subcutaneous, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2032
... to reach USD 471.1 billion by 2032 from USD 47.4 billion in 2024, at a CAGR of 33.2% during the forecast period. The key factors driving the growth of the GLP-1 Analogues market include the ... Read More
-
Global Glucose Analysis Tubes Market Analysis & Trends - Industry Forecast to 2030
... by 2030. Based on our analysis the market is expected to grow at a CAGR of 9.7% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include growing prevalence ... Read More
-
Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
... and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Patient Monitoring therapeutic area. An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. ... Read More
-
Diabetic Retinopathy Treatment
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Non-Proliferative Diabetic Retinopathy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$7.5 Billion ... Read More
Research Assistance
